89 related articles for article (PubMed ID: 26618902)
1. Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Giacomazzi J; Graudenz MS; Osorio CA; Koehler-Santos P; Palmero EI; Zagonel-Oliveira M; Michelli RA; Scapulatempo Neto C; Fernandes GC; Achatz MI; Martel-Planche G; Soares FA; Caleffi M; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
PLoS One; 2014; 9(6):e99893. PubMed ID: 24936644
[TBL] [Abstract][Full Text] [Related]
2. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
[TBL] [Abstract][Full Text] [Related]
3. Identification of the
Sandoval RL; Masotti C; de Macedo MP; Ribeiro MFSA; Leite ACR; Meireles SI; Bovolin RM; Santini FC; Munhoz RR; Jardim DLF; Katz A; Camargo AA; Fernandes GDS; Achatz MI
JCO Glob Oncol; 2021 Jul; 7():1141-1150. PubMed ID: 34270331
[TBL] [Abstract][Full Text] [Related]
4. The Clinical and Molecular Profile of Lung Cancer Patients Harboring the
Lopes CDH; Antonacio FF; Moraes PMG; Asprino PF; Galante PAF; Jardim DL; de Macedo MP; Sandoval RL; Katz A; de Castro G; Achatz MI
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894716
[TBL] [Abstract][Full Text] [Related]
5. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
Pinto EM; Fridman C; Figueiredo BC; Salvador H; Teixeira MR; Pinto C; Pinheiro M; Kratz CP; Lavarino C; Legal EAMF; Le A; Kelly G; Koeppe E; Stoffel EM; Breen K; Hahner S; Heinze B; Techavichit P; Krause A; Ogata T; Fujisawa Y; Walsh MF; Rana HQ; Maxwell KN; Garber JE; Rodriguez-Galindo C; Ribeiro RC; Zambetti GP
HGG Adv; 2024 Jan; 5(1):100244. PubMed ID: 37794678
[TBL] [Abstract][Full Text] [Related]
6. Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H in TP53.
Fitarelli-Kiehl M; Macedo GS; Schlatter RP; Koehler-Santos P; Matte Uda S; Ashton-Prolla P; Giacomazzi J
Genet Mol Biol; 2016 Jun; 39(2):203-9. PubMed ID: 27275664
[TBL] [Abstract][Full Text] [Related]
7. Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
Villacis RA; Miranda PM; Gomy I; Santos EM; Carraro DM; Achatz MI; Rossi BM; Rogatto SR
Int J Cancer; 2016 Apr; 138(8):1928-35. PubMed ID: 26620301
[TBL] [Abstract][Full Text] [Related]
8. Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.
Peters JA; Kenen R; Bremer R; Givens S; Savage SA; Mai PL
J Genet Couns; 2016 Jun; 25(3):529-42. PubMed ID: 26621765
[TBL] [Abstract][Full Text] [Related]
9. R337H mutation of the TP53 gene as a clinical marker in cancer patients: a systematic review of literature.
Borges LM; Ayres FM
Genet Mol Res; 2015 Dec; 14(4):17034-43. PubMed ID: 26681051
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Sampson JR; Capella G; Mecklin JP; Möslein G;
Gut; 2017 Mar; 66(3):464-472. PubMed ID: 26657901
[TBL] [Abstract][Full Text] [Related]
11. The Evolution of Tumors in Mice and Humans with Germline p53 Mutations.
Levine AJ; Chan CS; Dudgeon C; Puzio-Kuter A; Hainaut P
Cold Spring Harb Symp Quant Biol; 2015; 80():139-45. PubMed ID: 26642854
[TBL] [Abstract][Full Text] [Related]
12. Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.
Schiavi A; Lavigne J; Turcotte R; Kasprzak L; Dumas N; Chong G; Freeman C; Alameldin M; Galiatsatos P; Palma L; Foulkes WD
Curr Oncol; 2015 Oct; 22(5):317-25. PubMed ID: 26628864
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
Cheng TH; Thompson D; Painter J; O'Mara T; Gorman M; Martin L; Palles C; Jones A; Buchanan DD; Win AK; Hopper J; Jenkins M; Lindor NM; Newcomb PA; Gallinger S; Conti D; Schumacher F; Casey G; Giles GG; Pharoah P; Peto J; Cox A; Swerdlow A; Couch F; Cunningham JM; Goode EL; Winham SJ; Lambrechts D; Fasching P; Burwinkel B; Brenner H; Brauch H; Chang-Claude J; Salvesen HB; Kristensen V; Darabi H; Li J; Liu T; Lindblom A; Hall P; de Polanco ME; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Aguiar Jnr S; Teixeira MR; Dunning AM; Dennis J; Otton G; Proietto T; Holliday E; Attia J; Ashton K; Scott RJ; McEvoy M; Dowdy SC; Fridley BL; Werner HM; Trovik J; Njolstad TS; Tham E; Mints M; Runnebaum I; Hillemanns P; Dörk T; Amant F; Schrauwen S; Hein A; Beckmann MW; Ekici A; Czene K; Meindl A; Bolla MK; Michailidou K; Tyrer JP; Wang Q; Ahmed S; Healey CS; Shah M; Annibali D; Depreeuw J; Al-Tassan NA; Harris R; Meyer BF; Whiffin N; Hosking FJ; Kinnersley B; Farrington SM; Timofeeva M; Tenesa A; Campbell H; Haile RW; Hodgson S; Carvajal-Carmona L; Cheadle JP; Easton D; Dunlop M; Houlston R; Spurdle A; Tomlinson I
Sci Rep; 2015 Dec; 5():17369. PubMed ID: 26621817
[TBL] [Abstract][Full Text] [Related]
14.
Kou SH; Li J; Tam B; Lei H; Zhao B; Xiao F; Wang SM
NAR Cancer; 2023 Sep; 5(3):zcad025. PubMed ID: 37304756
[No Abstract] [Full Text] [Related]
15. Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.
Kwong A; Shin VY; Ho CYS; Au CH; Slavin TP; Weitzel JN; Chan TL; Ma ESK
BMC Cancer; 2020 Nov; 20(1):1053. PubMed ID: 33138793
[TBL] [Abstract][Full Text] [Related]
16. What 20 years of research has taught us about the TP53 p.R337H mutation.
Pinto EM; Zambetti GP
Cancer; 2020 Nov; 126(21):4678-4686. PubMed ID: 32875577
[TBL] [Abstract][Full Text] [Related]
17. TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence.
Seidinger AL; Caminha IP; Mastellaro MJ; Gabetta CS; Nowill AE; Pinheiro VRP; Yunes JA
Mol Genet Genomic Med; 2020 Sep; 8(9):e1168. PubMed ID: 32592449
[TBL] [Abstract][Full Text] [Related]
18. Penetrance of the
Costa TEJ; Gerber VKQ; Ibañez HC; Melanda VS; Parise IZS; Watanabe FM; Pianovski MAD; Fiori CMCM; Fabro ALMR; Silva DBD; Andrade DP; Komechen H; Mendes MC; Carboni E; Kuczynski AP; Souza EN; Paraizo MM; Ibañez MVC; Castilho LM; Cruz AF; Maia TFD; Machado-Souza C; Rosati R; Oliveira CS; Parise GA; Passos JDC; Barbosa JRS; Figueiredo MMO; Lima L; Tormen T; Sabbaga CC; Ávilla SGA; Grisa L; Aranha A; Tosin KCF; Ogradowski KRP; Lima G; Legal EF; Anegawa TH; Mazzuco TL; Grion AL; Balbinotti JHG; Dammski KL; Melo RG; Filho NK; Custódio G; Figueiredo BC
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31744167
[TBL] [Abstract][Full Text] [Related]
19. Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p.
Paskulin DD; Giacomazzi J; Achatz MI; Costa S; Reis RM; Hainaut P; dos Santos SE; Ashton-Prolla P
PLoS One; 2015; 10(11):e0143262. PubMed ID: 26618902
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
